Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

152 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q3 2020.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 101,459,246 shares of 315,976,000 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21,521,301 shares), TPG Group Holdings (SBS) Advisors, Inc. (16,213,367 shares), WELLINGTON MANAGEMENT GROUP LLP (15,411,025 shares), VANGUARD GROUP INC (10,766,283 shares), BlackRock Inc. (8,325,129 shares), Neuberger Berman Group LLC (3,685,477 shares), Eversept Partners, LP (2,656,208 shares), STATE STREET CORP (2,493,033 shares), GEODE CAPITAL MANAGEMENT, LLC (1,599,517 shares), and NORTHERN TRUST CORP (1,449,809 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.